跳至主要内容
临床试验/NCT05302661
NCT05302661Unknown不适用

Effect of Re-education on Rebleeding Rate After Endoscopic Treatment of Esophageal and/or Gastric Varices in Patients With Liver Cirrhosis

Qilu Hospital of Shandong University1 个研究点 分布在 1 个国家目标入组 508 人开始时间: 2022年2月19日最近更新:
适应症

试验速览

阶段
不适用
入组人数
508
试验地点
1
主要终点
rebleeding

研究概览

简要总结

A prospective, randomized controlled study on whether re-education after discharge can reduce the rebleeding rate after endoscopic treatment of esophageal and gastric varices in patients with liver cirrhosis

详细描述

After receiving esophageal variceal ligation and (or) gastric fundus variceal sclerotherapy, patients with outside hospitalthe rate of bleeding due to liver cirrhosis shall be re-educated outside the hospital, including diet, drugs, anticoagulation of portal vein thrombosis,regular endoscopic treatment, reexamination , nutrition, etc. The patients were divided into the first treatment group and the more thanonce treatment group according to whether they had received endoscopic treatment in the past

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Esophageal and / or gastric varices ;
  • liver cirrhosis ;
  • patients receiving endoscopic treatment (esophagogastric variceal sclerosis and/or ligation) ;
  • All subjects or their guardians must sign the subject consent form before entering the test

排除标准

  • Patients with mental illness, severe hearing loss and unable to take care of themselves ;
  • ASA score ≥ grade IV at discharge ;
  • Hepatic encephalopathy ≥ stage II;
  • Patients with liver cancer;
  • Pregnant and lactating women;
  • Patients who cannot sign informed consent

结局指标

主要结局

rebleeding

时间窗: 2 yeas

rebleeding from any channel can be followed up through medical institutions or telephone

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验